Swe­den's Cal­lid­i­tas seeks $75M IPO haul to bring its oral steroid to pa­tients with an or­phan kid­ney dis­ease

As biotech af­ter biotech elic­its en­thu­si­as­tic in­vestor sup­port for this cor­ner of the IPO mar­ket, a Swedish play­er is join­ing the Nas­daq line to fund …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.